Advertisement

Is neurotransmitter release involved in the mechanism of general anesthesia?

  • Kazuyoshi HirotaEmail author
  • Tetsuya Kushikata
  • Daiki Takekawa
  • Mihoko Kudo
Short Communication
  • 27 Downloads

Abstract

Introduction

It is believed that neurotransmitters release modulates general anesthesia via several receptors system which are molecular targets for anesthetic agents in young-adult rats. However, middle-aged rats have rarely been used. Therefore, we studied in this age group.

Materials and Methods

After approval of our protocol by the institutional committee on animal research, 116 middle aged Sprague–Dawley rats were assigned to ketamine (K: n = 74) and propofol (P: n = 42) anesthesia groups. Rats were decapitated 0, 20 60 and 120 min after ip K (100 mg/kg) or P (80 mg/kg), respectively. Melanin-concentrating hormone (MCH), orexin A (OXA) and noradrenaline contents in the pons, hypothalamus, hippocampus and cerebrocortex were measured by a commercial enzyme-linked immunosorbent assay (ELISA) or high-performance liquid chromatography.

Results

Neurotransmitter content in all brain regions did not significantly change following K or P administration.

Conclusion

Therefore, we question whether neurotransmitter release contributes to general anesthesia.

Keywords

Neurotransmitter release Aging Rats Mechanism of general anesthesia 

Notes

Acknowledgements

We thank Professor David G Lambert (University Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, Leicester Royal infirmary, Leicester, UK) for his valuable comments.

References

  1. 1.
    Kushikata T, Sawada M, Niwa H, Kudo T, Kudo M, Tonosaki M, Hirota K. Ketamine and propofol have opposite effects on postanesthetic sleep architecture in rats: relevance to the endogenous sleep-wakefulness substances orexin and melanin-concentrating hormone. J Anesth. 2016;30:437–43.CrossRefGoogle Scholar
  2. 2.
    Hirota K, Kushikata T. Central noradrenergic neurons and the mechanism of general anaesthesia. Br J Anaesth. 2001;87:811–3.CrossRefGoogle Scholar
  3. 3.
    Kushikata T, Yoshida H, Kudo M, Kudo T, Kudo T, Hirota K. Role of cerulean noradrenergic neurones in general anaesthesia in rats. Br J Anaesth. 2011;107:924–9.CrossRefGoogle Scholar
  4. 4.
    Kushikata T, Hirota K, Yoshida H, Kudo M, Lambert DG, Smart D, Jerman JC, Matsuki A. Orexinergic neuron and barbiturate anesthesia. Neuroscience. 2003;121:855–63.CrossRefGoogle Scholar
  5. 5.
    Tose R, Kushikata T, Yoshida H, Kudo M, Furukawa K, Ueno S, Hirota K. Orexin A decreases ketamine-induced anesthesia time in the rat: the relevance to brain noradrenergic neuronal activity. Anesth Analg. 2009;108:491–5.CrossRefGoogle Scholar
  6. 6.
    Kushikata T, Yoshida H, Kudo M, Salvadori S, Calo G, Hirota K. The effects of neuropeptide S on general anesthesia in rats. Anesth Analg. 2011;112:845–9.CrossRefGoogle Scholar
  7. 7.
    Hirota K, Kushikata T, Kudo M, Kudo T, Smart D, Matsuki A. Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle aged rats. Brain Res. 2003;981:143–50.CrossRefGoogle Scholar
  8. 8.
    Pritchard R, Chen H, Romoli B, Spitzer NC, Dulcis D. Photoperiod-induced neurotransmitter plasticity declines with aging: an epigenetic regulation? J Comp Neurol. 2019.  https://doi.org/10.1002/cne.24747.CrossRefPubMedGoogle Scholar
  9. 9.
    Franks NP, Zecharia AY. Sleep and general anesthesia. Can J Anaesth. 2011;58:139–48.CrossRefGoogle Scholar
  10. 10.
    Song AH, Kucyi A, Napadow V, Brown EN, Loggia ML, Akeju O. Pharmacological modulation of noradrenergic arousal circuitry disrupts functional connectivity of the locus ceruleus in humans. J Neurosci. 2017;37:6938–45.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Anesthesiologists 2019

Authors and Affiliations

  1. 1.Department of AnesthesiologyHirosaki University Graduate School of MedicineHirosakiJapan

Personalised recommendations